Header Logo

Connection

PADMANEE SHARMA to Everolimus

Back to Details
This is a "connection" page, showing publications PADMANEE SHARMA has written about Everolimus.
PADMANEE SHARMA
Connection Strength
0.145
Everolimus
  1. CheckMate 025 Randomized Phase 3 Study: Outcomes by Key Baseline Factors and Prior Therapy for Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma. Eur Urol. 2017 12; 72(6):962-971.
    View in: PubMed
    Score: 0.119
  2. Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma. N Engl J Med. 2015 Nov 05; 373(19):1803-13.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.